Florida in 1996. He has worked extensively and published on FX Syndrome and is very familiar with ëFragile X-Associated Tremor Ataxia Syndromeí (FXTAS) discovered at the M.I.N.D. Institute. He is presenting today on the ěResearch Advances in FXTASî.
Dr. Vicki Wheelock received her Biomedical Sciences degree from the University of Michigan. She became an M.D. also at the University of Michigan Medical School, Ann Arbor, MI in 1983. She is the Director of the Movement disorders Program and Huntington Disease Program at UC Davis Medical Center. These Programs in addition to symptomatic treatments have a stereotactic neurosurgery program, which provides presurgical evaluation, deep brain stimulation and stereotaxic functional neurosurgery, and postoperative management. The Movement disorders Clinic serves as the Northern Californiaís referral system for the state funded Genetically Handicapped Persons Program (GHPP). This clinic focuses on patients with Friedreich's ataxia, Huntington's disease, Joseph's disease and other genetically determined diseases. Today she will speak on ěUpdate on the Genetics of Ataxiaî.
Dr. Susan Perlman serves as Clinical Professor of Neurology and as the Director of the Ataxia Center at the University of California at Los Angeles. Dr. Perlman has been involved, since 1979, with the evaluation, diagnosis, and symptomatic treatment of people with inherited and acquired ataxia. In the past ten years, over 1,000 patients have been seen. The Ataxia Center at UCLA collaborates with other ataxia research groups and patient support organizations around the country and the world The Ataxia Center professional staff includes Dr Dan Geschwind, Dr Joanna Jen, Dr. Stephen Cederbaum, Dr. Richard Gatti, and Dr. Stefan Pulst. Dr. Perlman has funding from the National Ataxia Foundation for her important ataxia research efforts and she is also a member of the National Ataxia Foundationís Medical and Research Advisory Board. Today she will present on ěReview of Anti-oxidants and their Role in Genetic and Non-genetic Ataxiasî.
Dr. Allen Christian works in the Biology Biotechnology Research Program at Lawrence Livermore National Lab. He received his Ph.D. in Radiation Biology from Colorado State University.Ý Dr. Christian is currently working as the Bioengineering Group Leader of the Biodefense Division in the Biology and Biotechnology Research Program at Lawrence Livermore National Laboratory (LLNL). He runs two labs at LLNL and he works extensively with siRNA. Gene silencing (siRNA) holds many hopes for most dominant hereditary diseases as a possible treatment. One of his latest publications is: ěVarying the Nucleic Acid Composition of siRNA Molecules Dramatically varies the Duration and Degree of Gene Silencing.î This meeting he will be speaking on: ëBetween RNA Interference and the Clinicí
Dr. Henry ëHankí Paulson received his Medical Degree from Yale University School of Medicine, and his Ph.D. in Cell Biology from Yale University School of Medicine. Dr. Paulson served his residency in Neurology at the University of Pennsylvania. Currently he serves as a professor of Neurology at the University of Iowa College of medicine. Since beginning his work on SCA3/MJD in 1996, Dr. Paulsonís lab has published many studies on MJD, and is reaching for a treatment or cure. Dr. Paulson is a member of National Ataxia Foundationís Research Advisory Board and a member of the prestigious ëCooperative Ataxia Groupí. He has received funding from NAF as well as the Ataxia MJD Research Project and NIH to research SCA3/MJD. Dr. Paulsonís research into Gene Silencing (siRNA) may hold some interesting announcements for all dominant hereditary Ataxias. He is ACARMís special guest today and comes all the way from Iowa. Today he will talk on ěWhat is RNA interference? And whatís up with it?.
National Ataxia Foundation